BMA revives Grey Line plans

BMA revives Grey Line plans

The Bangkok Metropolitan Administration plans to revive the Grey Line electric monorail project. (Bangkok Post photo)
The Bangkok Metropolitan Administration plans to revive the Grey Line electric monorail project. (Bangkok Post photo)

The Bangkok Metropolitan Administration (BMA) plans to revive the Grey Line electric monorail project, with the first phase of construction expected to begin in 2021, deputy Bangkok governor Sakoltee Phattiyakul says.

The deputy governor said BMA officials are conducting a feasibility study and an environmental impact assessment. He said the project is divided into three phases.

The first phase is planned for soi Watcharapol on Ram Intra Road to soi Thong Lor on Sukhumvit Road. The second phase will be from the Phra Khanong area  to Rama III Road while the final phase is planned for Rama III Road to the Tha Phra area.

However, the second phase of construction may be slightly delayed because the BMA needs some time to negotiate land expropriation issues with locals living along the planned route, Mr Sakoltee said, adding that the first and third phases are expected to begin first in 2021.

He also said that a survey showed 80% of residents along the entire route agreed with the project as they believed it would make their city commute easier.


Do you like the content of this article?
COMMENT (10)

SCB shares at 25-month high on news

Siam Commercial Bank saw its share price reach a 25-month high after markets opened on Thursday, following its announcement of a major restructuring plan and new venture capital fund with Charoen Pokphand Group.

12:36

Two rivers burst banks, flooding two Korat districts

NAKHON RATCHASIMA: The Lam Takhong and Lam Chiang Krai rivers burst their banks, sending a huge volume of water to flood many houses in Nong Sung and Muang districts on Thursday.

11:55

US FDA clears Pfizer booster for high-risk groups

WASHINGTON: The US Food and Drug Administration on Wednesday authorised a booster dose of the Pfizer Inc and BioNTech Covid-19 vaccine for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus.

11:35